Cellular Biomedicine Group, Inc. - FORM 10-K - EX-21.1 - SUBSIDIARIES OF THE COMPANY - March 5, 2018

Attached files

file	filename
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Cellular Biomedicine Group, Inc.	cbmg_ex32.htm
EX-31 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Cellular Biomedicine Group, Inc.	cbmg_ex31.htm
EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - Cellular Biomedicine Group, Inc.	cbmg_ex231.htm
10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc.	cbmg_10k.htm

Exhibit 21.1

List of Subsidiaries of Cellular Biomedicine Group, Inc.:

Name		State of Incorporation/Formation
Cellular Biomedicine Group Ltd.		Hong Kong
Cellular Biomedicine Group (Wuxi) Ltd.		People’s Republic of China
Cellular Biomedicine Group (Shanghai) Ltd.		People’s Republic of China (variable interest entity)
Beijing Agreen Biotechnology Co., Ltd.		People’s Republic of China (100% owned by Cellular Biomedicine Group (Shanghai) Ltd.)
Shanghai Cellular Biopharmaceutical Group Ltd.		People’s Republic of China (100% owned by Cellular Biomedicine Group (Shanghai) Ltd.)
Wuxi Cellular Biopharmaceutical Group Ltd.		People’s Republic of China (100% owned by Cellular Biomedicine Group (Shanghai) Ltd.)
Eastbridge Investment Corporation		Delaware
Cellular Biomedicine Group Vax, Inc.		California